 All consecutive consenting patients recently diagnosed 6 months with CTEPH at participating study sites will be enrolled. At the time of study entry, data on prior history and evaluation will be obtained from patient interview and review of medical records. Patients will be followed biannually after enrollment until the conclusion of the study minimum of 1 year follow-up for final patients enrolled. 